The incretin pathway as a therapeutic target in diabetic kidney disease: a clinical focus on GLP-1 receptor agonists.

Michaël J.B. van Baar,Annemarie B. van der Aart,K Hoogenberg,Jaap A. Joles,Hiddo J.L. Heerspink,Daniël H. van Raalte

The incretin pathway as a therapeutic target in diabetic kidney disease: a clinical focus on GLP-1 receptor agonists.

2019

Michaël J.B. van Baar
Annemarie B. van der Aart
K Hoogenberg
Jaap A. Joles
Hiddo J.L. Heerspink
Daniël H. van Raalte

Diabetic kidney disease (DKD) remains the main cause for chronic kidney disease (CKD) and end-stage kidney disease (ESKD) worldwide. Both CKD and ESKD lead to major increases in risk of cardiovascu...

Keywords:

Glucagon-like peptide 1 receptor
Endocrinology
Internal medicine
Diabetes mellitus
Medicine
Kidney disease
Incretin
Blood pressure
Albuminuria
Bioinformatics
Residual risk
Disease

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations